The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| HNL | -8.42% | -87.87% | -34.41% | -35% |
| S&P | +15.66% | +86.6% | +13.29% | +406% |
Dr. Hönle AG engages in the development, manufacture, and sale of light-emitting diode ultraviolet (UV) products. It operates through the following segments: Equipment and Systems; Adhesives; and Glass and Lamps. The Equipment and Systems offers UV products that are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and sunlight simulation. The Adhesive segment includes industrial adhesives for a spectrum of applications. The Glass and Lamp segment comprises of quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries as well as lamps for water sterilization and drying of coatings and adhesives. The company was founded by Karl Hönle and Günter Schmid in 1976 and is headquartered in Gilching, Germany.
No news articles found for Hoenle Ag.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $22.64M | -5.5% |
| Gross Profit | $2.57M | -26.2% |
| Gross Margin | 11.34% | -3.2% |
| Market Cap | $57.47M | -47.2% |
| Market Cap / Employee | $101.17K | 0.0% |
| Employees | 568 | -0.9% |
| Net Income | -$921.00K | -269.9% |
| EBITDA | $564.00K | -57.2% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $5.91M | -11.7% |
| Accounts Receivable | $12.89M | -8.2% |
| Inventory | 29.8 | -14.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $35.33M | -11.7% |
| Short Term Debt | $15.47M | 1.4% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -8.54% | -5.4% |
| Return On Invested Capital | -3.37% | -4.6% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $975.00K | 838.6% |
| Operating Free Cash Flow | $1.44M | 83.6% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.76 | 0.49 | 0.67 | 0.72 | -37.73% |
| Price to Sales | 0.72 | 0.47 | 0.54 | 0.60 | -46.00% |
| Price to Tangible Book Value | 0.96 | 0.62 | 0.80 | 0.86 | -41.41% |
| Price to Free Cash Flow TTM | 21.23 | 32.45 | 29.20 | 19.61 | -57.37% |
| Enterprise Value to EBITDA | -122.02 | 89.90 | 50.59 | 181.70 | 52.09% |
| Free Cash Flow Yield | 4.7% | 3.1% | 3.4% | 5.1% | 134.58% |
| Return on Equity | -15.1% | -15.1% | -15.0% | -15.8% | 184.72% |
| Total Debt | $53.33M | $54.23M | $52.52M | $50.80M | -8.09% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
